SPOTLIGHT -
Compensation Overkill
Congress-and the public-needs to take a deep breath before making a big mistake.
Ad(Ventures) in Pharmaland
Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration.
2009 PharmExec Top 50
We leap tall buildings to bring you the definitive guide to the world's top pharmaceutical companies.
Behavior and the Bottom Line
In an era of shrinking marketing budgets, increase ROI with behavioral science-based marketing.
A Day Late and a Dollar Short
Pharma marketers face a crisis in digital media. But there's a way to turn it around.
The Shakeout
When it comes to licensing in this market, there are winners and losers. Learn the new rules of the game.
Bank on IT
Tough economic tmes call for a bold approach to evolving information technology solutions.
Weathering the Storm
Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market.
Compared to What?
Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.
Another Dimension
Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?